AI Chat Paper
Discover the SciOpen Platform and Achieve Your Research Goals with Ease.
Search articles, authors, keywords, DOl and etc.
{{expandStatus?'Exit ':''}}Advanced Search
The Annual Report on Cardiovascular Health and Diseases in China (2022) intricate landscape of cardiovascular health in China. In connection with the previous section, this seventh section of the report offers a comprehensive analysis of disorders of heart rhythm in China. In 2021, China has achieved significant development and gratifying results in many aspects of the field of arrhythmia. Left bundle branch pacing (LBBP), as an emerging pacing technique originating from China, has received widespread attention. New research results have emerged on its indications, surgical procedures, clinical evaluation, and comparison with other pacing techniques. Its feasibility, effectiveness, and safety have been basically verified, but its long-term prognosis still needs further confirmation from larger samples and longer follow-up time research results. Leadless pacemakers have begun to be used in a wider range of clinical applications, and related large sample cohort studies have been reported. In addition, there are also noteworthy new achievements in the fields of pacemaker remote programming, anticoagulation and radiofrequency catheter ablation (RFCA) therapy for atrial fibrillation, and implantable cardioverter defibrillator prevention of sudden cardiac death. In terms of clinical practice, due to COVID-19 pandemic, the number of RFCA procedures and other device implantations in China has fluctuated, but it has gradually recovered since 2020.
Lin GF, Zou T, Dong M, et al. Risk stratifying and prognostic analysis of subclinical cardiac implantable electronic devices infection: insight from traditional bacterial culture. J Am Heart Assoc 2021; 10: e022260.
Liu YM, Cao Y, Xu ZM, et al. Influence of dual antiplatelet therapy on pocket bleeding complications at the time of pacemaker implantation. Asian J Surg 2022; 45: 1053−1054.
Tong L, Xiong SQ, Hou J, et al. Cloud follow-up in patients with cardiovascular implantable electronic devices: a single-region study in China. Front Cardiovas Med 2022; 9: 864398.
Chen X, Liu HX, Lin T, et al. Clinical use of real-time remote programming in pacemakers during the COVID-19 pandemic: a case report. Pacing Clin Electrophysiol 2022; 45: 815−817.
Ning XH, Li XF, Fan XH, et al. 3. 0 T magnetic resonance imaging scanning on different body regions in patients with pacemakers. J Interv Cardiac Electrophysiol 2021; 61: 545−550.
Li XF, Li H, Ma WT, et al. Permanent left bundle branch area pacing for atrioventricular block: feasibility, safety, and acute effect. Heart Rhythm 2019; 16: 1766−1773.
Zhang JM, Wang ZF, Zu LN, et al. Simplifying physiological left bundle branch area pacing using a new nine-partition method. Can J Cardiol 2021; 37: 329−338.
Liu X, Niu HX, Gu M, et al. Contrast-enhanced image-guided lead deployment for left bundle branch pacing. Heart Rhythm 2021; 18: 1318−1325.
Hua W, Fan XH, Li XF, et al. Comparison of left bundle branch and his bundle pacing in bradycardia patients. JACC Clin Electrophysiol 2020; 6: 1291−1299.
Peng XY, Chen Y, Wang XF, et al. Safety and efficacy of his-bundle pacing/left bundle branch area pacing versus right ventricular pacing: a systematic review and meta-analysis. J Interv Cardiac Electrophysiol 2021; 62: 445−459.
Qu Q, Sun JY, Zhang ZY, et al. His-purkinje conduction system pacing: a systematic review and network meta-analysis in bradycardia and conduction disorders. J Cardiovasc Electrophysiol 2021; 32: 3245−3258.
Yuan ZY, Cheng LT, Wu YQ, et al. Meta-analysis comparing safety and efficacy of left bundle branch area pacing versus his bundle pacing. Am J Cardiol 2022; 164: 64−72.
Chen XY, Jin QC, Bai J, et al. The Feasibility and Safety of Left Bundle Branch Pacing vs Right Ventricular Pacing after Mid-Long-Term Follow-Up: A Single-Centre Experience. Europace 2020; 22: ii36−ii44.
Li XF, Zhu HJ, Fan XH, et al. Tricuspid regurgitation outcomes in left bundle branch area pacing and comparison with right ventricular septal pacing. Heart Rhythm 2022; 19: 1202−1203.
Liu X, Li WB, Zeng JP, et al. Evaluation of clinical safety and efficacy of left bundle branch area pacing in comparison with right ventricular septal pacing. Medicine 2022; 101: e29071.
Wang Z, Zhu HJ, Li XF, et al. Left bundle branch area pacing versus right ventricular pacing in patients with persistent atrial fibrillation requiring ventricular pacing. Pacing Clin Electrophysiol 2021; 44: 2024−2030.
Zhu HJ, Wang Z, Li XF, et al. The Initial experience of left bundle branch area pacing in patients with hypertrophic cardiomyopathy. Pacing Clin Electrophysiol 2022; 45: 1065−1074.
Zhang JF, Pan YW, Wang B, et al. Current opinions on new-onset left bundle branch block after transcatheter aortic valve replacement and the search for physiological pacing. Rev Cardiovasc Med 2022; 23: 90.
Su L, Wang SJ, Wu SJ, et al. Long-term safety and feasibility of left bundle branch pacing in a large single-center study. Circ Arrhythm Electrophysiol 2021; 14: e009261.
Wu SJ, Chen XY, Wang SJ, et al. Evaluation of the criteria to distinguish left bundle branch pacing from left ventricular septal pacing. JACC Clin Electrophysiol 2021; 7: 1166−1177.
Chen X, Qian ZY, Zou FW, et al. Differentiating left bundle branch pacing and left ventricular septal pacing: an algorithm based on intracardiac electrophysiology. J Cardiovasc Electrophysiol 2022; 33: 448−457.
Zhang JH, He L, Xing Q, et al. Evaluation of safety and feasibility of leadless pacemaker implantation following the removal of an infected pacemaker. Pacing Clin Electrophysiol 2021; 44: 1711−1716.
Shi SB, Tang YH, Zhao QY, et al. Prevalence and Risk of Atrial Fibrillation in China: a National Cross-Sectional Epidemiological Study. Lancet Reg Health West Pac 2022; 23: 100439.
Wu L, Liang E, Fan SY, et al. Relation of left atrial appendage morphology determined by computed tomography to prior stroke or to increased risk of stroke in patients with atrial fibrillation. Am J Cardiol 2019; 123: 1283−1286.
Chang SS, Dong JZ, Ma CS, et al. Current status and time trends of oral anticoagulation use among chinese patients with nonvalvular atrial fibrillation: the Chinese atrial fibrillation registry study. Stroke 2016; 47: 1803−1810.
Bai Y, Liu XY, Liu Y, et al. Prevalence of Recommended Anticoagulation by Guidelinespreadmission and Its Impact on the Incidence of Acute Myocardial Infarction (AMI) and In-Hospital Outcomes after AMI in Atrial Fibrillation Patients. J Thromb Thrombolysis 2022; 54: 91−96.
Zhu L, Zhang XD, Wang J, et al. Analysis of influencing factors of compliance with non-vitamin K antagonist oral anticoagulant in patients with nonvalvular atrial fibrillation and correlation with the severity of ischemic stroke. Evid Based Complement Alternat Med 2021; 2021: 1021127.
Liu Y, Zhan XZ, Xue YM, et al. Incidence and outcomes of cerebrovascular events complicating catheter ablation for atrial fibrillation. Europace 2016; 18: 1357−1365.
Zhang T, Wang YL, Liang Z, et al. Effect of combined pulmonary vein and superior vena cava isolation on the outcome of second catheter ablation for paroxysmal atrial fibrillation. Am J Cardiol 2020; 125: 1845−1850.
Wu G, Huang H, Cai L, et al. Long-Term Observation of Catheter Ablation vs. Pharmacotherapy in the Management of Persistent and Long-Standing Persistent Atrial Fibrillation (CAPA Study). Europace 2021; 23: 731−739.
Wang SW, Cui H, Song CP, et al. Obstructive sleep apnea is associated with nonsustained ventricular tachycardia in patients with hypertrophic obstructive cardiomyopathy. Heart Rhythm 2019; 16: 694−701.
Chen B, Li JY, Li SJ, et al. Risk factors for left ventricle enlargement in children with frequent ventricular premature complexes. Am J Cardiol 2020; 131: 49−53.
Zhang JH, Zhou XH, Xing Q, et al. Epidemiological investigation of sudden cardiac death in multiethnic xinjiang uyghur autonomous region in Northwest China. BMC Public Health 2019; 19: 116.
Ching CK, Hsieh YC, Liu YB, et al. The mortality analysis of primary prevention patients receiving a Cardiac Resynchronization Defibrillator (CRT-D) or Implantable Cardioverter-Defibrillator (ICD) According to Guideline Indications in the IMPROVE SCA Study. J Cardiovasc Electrophysiol 2021; 32: 2285−2294.
Zhang S, Ching CK, Huang DJ, et al. Utilization of implantable cardioverter-defibrillators for the prevention of sudden cardiac death in emerging countries: IMPROVE SCA clinical trial. Heart Rhythm 2020; 17: 468−475.
Huang D, Hua W, Fang Q, et al. Biventricular pacemaker and defibrillator implantation in patients with chronic heart failure in China. ESC Heart Failure 2021; 8: 546−554.
Gao YF, Liu WL, Li CL, et al. Common genotypes of long QT syndrome in China and the role of ECG prediction. Cardiology 2016; 133: 73−78.
Kwok SY, Liu APY, Chan CY, et al. Clinical and genetic profile of congenital long QT syndrome in Hong Kong: a 20-year experience in pediatrics. Hong Kong Med J 2018; 24: 561−570.
Jiang H, Li XM, Ge HY, et al. Investigation of Catecholaminergic Polymorphic Ventricular Tachycardia in Chinese Children: Clinical Characteristics, Delay to Diagnosis, and Misdiagnosis. Chin Med J (Engl) 2018; 131: 2864−2865.
Hua W, Fan XH, Su YG, et al. The Efficacy and Safety of Cardiac Contractility Modulation in Patients with Nonischemic Cardiomyopathy: Chinese Experience. Int J Heart Rhythm 2017; 2: 29−33.
302
Views
21
Downloads
0
Crossref
0
Web of Science
0
Scopus
0
CSCD
Altmetrics
京公网安备11010802044758号